Moreover, our findings also agree with a whole-genome sequencing study22 showing more frequent mutations or losses of CDKN2A (6/9 tumors) than TP53 (3/9 tumors) in human pancreatic tumors carrying ATM mutations. Here, TP53 is linked to pancreatic neoplasm.